rethinkPeptides Search
Menu
Research citation

Cilengitide: the first anti-angiogenic small molecule drug candidate design, synthesis and clinical evaluation.

evidence

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

Cilengitide: the first anti-angiogenic small molecule drug candidate design, synthesis and clinical evaluation.

Anti-cancer agents in medicinal chemistry, 10(10), 753-68

Citation

Mas-Moruno, Carlos; Rechenmacher, Florian; Kessler, Horst. (2010). Cilengitide: the first anti-angiogenic small molecule drug candidate design, synthesis and clinical evaluation.. Anti-cancer agents in medicinal chemistry, 10(10), 753-68.